Evaluating drug treatments for Parkinson's disease: how good are the trials?
- 22 June 2002
- Vol. 324 (7352) , 1508-1511
- https://doi.org/10.1136/bmj.324.7352.1508
Abstract
Identifying trials and extracting data To identify publications from 1966 to the end of 2001 we searched the Cochrane Library, NHS Centre for Reviews and Dissemination, and Health Technology Assessment databases for systematic reviews and Medline, Embase, PubMed, and the Web of Science for primary research. We hand searched major journals in the field, including Movement Disorders, Parkinsonism and Related Disorders, Neurology, and Journal of Neurology, Neurosurgery and Psychiatry. We contacted experts in the field in attempt to identify studies not found through electronic and hand searching, and scanned reference lists of retrieved papers and websites relating to Parkinson's disease. No restriction on study design was made other than randomisation. Unpublished and non-randomised studies were not included.Keywords
This publication has 18 references indexed in Scilit:
- Treatment interventions for Parkinson's disease: an evidence based assessmentThe Lancet, 2002
- MEDICAL MANAGEMENT OF PARKINSON'S DISEASEJournal of Neurology, Neurosurgery & Psychiatry, 2002
- The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trialsThe Lancet, 2001
- A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or LevodopaNew England Journal of Medicine, 2000
- Pramipexole for levodopa-induced complications in Parkinson's diseaseCochrane Database of Systematic Reviews, 2000
- Effect of adding selegiline to levodopa in early, mild Parkinson's disease. Formal systematic review of data on patients in all relevant trials is required.1998
- ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.1995
- Depression and Parkinson's disease: a reviewAmerican Journal of Psychiatry, 1992
- Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards.1992
- The Nighttime Problems of Parkinsonʼs DiseaseClinical Neuropharmacology, 1988